Bumetanide
- Product NDC
- 51672-4223
- 11-digit product format
- 516724223
- Labeler code
- 51672
- Product ID
- 51672-4223_4db68936-9d9c-1821-e063-6394a90a7f1b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Bumetanide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Sun Pharmaceutical Industries, Inc.
- Application
- ANDA213458
- Marketing category
- ANDA
- Marketing start
- 2023-07-24
- Substance
- BUMETANIDE
- Active strength
- .5 mg/1
- Pharmacologic classes
- Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Bumetanide
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| BUMETANIDE | .5 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 0Y2S3XUQ5H |
| Rxcui | 197417, 197418, 197419 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 51672-4223-1 | Bumetanide | 100 in 1 BOTTLE | TABLET | 100 | | 5 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 51672-4223 | BUMETANIDE TABLET [TARO PHARMACEUTICALS U.S.A., INC.] | 4 | Current NDC, 1 package rows | 20240522_5c753aae-77b7-4add-8453-385a8f62d7db.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 51672-4223-1 | 51672422301 | 100 TABLET in 1 BOTTLE (51672-4223-1) | 100 tablet | 2023-07-24 | No | No | Historical |